Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877667 · ClinicalTrials.gov registry record · NA
Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol
A NA study of Tattoo, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02877667 is a NA study of Tattoo that has completed, run by Soliton. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02877667, a NA study of Tattoo, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.
Conditions Studied
Interventions
- DEVICE planar acoustic wave device
Study Locations (1)
Massachusetts
- SkinCare Physicians - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02877667
The ClinicalTrials.gov registry entry for NCT02877667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soliton, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tattoo appearing as the primary indexed condition, and to 1 intervention - of which planar acoustic wave device is the first listed.
NCT02877667 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02877667 about?
NCT02877667 is a clinical study titled "Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol". Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.
What is the current status of trial NCT02877667?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-07. Estimated completion is 2017-04-30.
What conditions does trial NCT02877667 study?
This clinical trial studies the following conditions: Tattoo.
What interventions are being tested in trial NCT02877667?
The interventions under investigation include: planar acoustic wave device (DEVICE).
Who is sponsoring clinical trial NCT02877667?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02877667 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.